Name: Bluejay Diagnostics, Inc. (BJDX) Financial Statements
Creator: FinSpry

Bluejay Diagnostics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Bluejay Diagnostics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.25	0.00	0.00
Cost of Revenue	0.20	0.00	0.20	0.00	0.00
Gross Profit	-0.20	0.00	0.05	0.00	0.00
Operating Expenses
Research & Development	3.47	5.71	4.15	1.15	0.53
Selling, General & Administrative	3.70	4.60	5.21	2.08	0.67
Operating Expenses	7.17	10.31	9.37	3.23	1.20
Operating Income	-7.17	-10.31	-9.32	-3.23	-1.20
Other Income/Expense
Interest Income	0.15	0.16	0.09	0.00	0.00
Interest Expense	0.82	0.00	0.00	-0.51	-0.14
Other Income/Expense	0.13	0.19	-0.07	0.25	0.08
Income
Income Before Tax	-7.72	-9.95	-9.30	-3.49	-1.16
Income Tax Expense	0.00	16.80	10.80	0.00	0.00
Net Income	-7.72	-9.95	-9.30	-3.49	-1.16
Net Income - Continuous Operations	-7.72	-9.95	-9.30	-3.49	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-6.70	-9.66	-9.01	-3.08	-1.04
EBIT	-6.89	-10.31	-9.32	-3.23	-1.20
Depreciation & Amortization	0.20	0.65	0.16	0.15	0.16
Earnings Per Share
Basic EPS	-457.00	-3632.00	-9.00	-5555.00	-
Diluted EPS	-457.00	-3632.00	-9.00	-5555.00	-
Basic Shares Outstanding	0.05	0.00	1.01	0.00	0.00
Diluted Shares Outstanding	0.05	0.00	1.01	0.00	0.00